BLIS Technologies Ltd
About BLIS Technologies Ltd
Certifications
-
FDA -
ISO
Categories
-
Country/Region:New Zealand
-
On CPHI since:2024
-
Certificates:2
-
Employees:25 - 49
Company types
Primary activities
Products from BLIS Technologies Ltd (2)
-
Product BLIS K12™ (Streptococcus salivarius K12)
BLIS K12™ (Streptococcus salivarius K12) is an oral probiotic to support mouth and throat. It originates from the oral microbiome and targets multiple concerns, including ENT (ears, nose and throat) health, immunity and bad breath. • Helps maintain a healthy oral microbiome • Supports ear, nose, and ... -
Product BLIS M18™ (Streptococcus salivarius M18)
BLIS M18™ (Streptococcus salivarius M18) is an oral probiotic to support teeth and gum health. It originates from the oral microbiome and is proven to maximise good dental hygiene, for the support of teeth, gums and overall health.
BLIS Technologies Ltd Resources (2)
-
News BLIS Technologies Enters the Pet Health Category with Clinically-Studied Oral Probiotics for Dogs
BLIS K12™ and BLIS M18™ — the world's first commercialised oral probiotic strains — extend their 25-year human health heritage into companion animal care, addressing one of the most prevalent yet under-treated conditions in dogs.
-
Video PROBIOTICS MADE TO MATTER | BLIS TECHNOLOGIES
BLIS Technologies are the masters of the oral microbiome. We are dedicated to discovering, developing, and supplying clinically validated probiotic strains that support oral and upper respiratory health. We were the first to discover Streptococcus salivarius probiotics — BLIS K12™ and BLIS M18™ — and we’ve been leading the science of the oral cavity ever since. BLIS K12™ and BLIS M18™ are backed by decades of research, strong IP, and extensive clinical validation.